Halozyme Therapeutics Stock Target Price and Analyst Consensus
| HALO Stock | USD 45.70 0.06 0.13% |
The current analyst and expert consensus on Halozyme Therapeutics is Buy with 5 hold recommendations. The current projected Halozyme Therapeutics target price consensus is 51.90 with 11 analyst opinions. One of the most common ways Halozyme Therapeutics analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Halozyme Therapeutics vendors, executives, and/or customers. Halozyme Therapeutics recommendation module provides expert sentiment on the projected Halozyme Therapeutics target price to derive its highest and lowest estimates based on target price standard deviation of 3.7155.
Lowest Forecast 47.23 | Highest Forecast 57.61 | Target Price 51.9 |
Halozyme |
It's important to approach Halozyme Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Halozyme Therapeutics price targets
Halozyme Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Halozyme Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Halozyme Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Halozyme Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Halozyme Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Halozyme Therapeutics is a key component of Halozyme Therapeutics valuation and have some predictive power on the future returns of a Halozyme Therapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Automobiles and Trucks Invested over 200 shares | |
 | Social Domain Invested few shares | |
 | Momentum Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Baby Boomer Prospects Invested over 40 shares | |
 | Hedge Favorites Invested over 50 shares | |
 | Tech Growth Invested few shares | |
 | Corona Opportunity Invested few shares | |
 | Defense Sold few shares | |
 | Driverless Cars Invested few shares | |
 | Manufacturing Invested over 30 shares | |
 | Business Services Invested few shares |
Check out Macroaxis Advice on Halozyme Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Halozyme Stock, please use our How to Invest in Halozyme Therapeutics guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..